These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3623627)

  • 61. Imaging in the diagnosis and management of Vogt-Koyanagi-Harada disease.
    Jap A; Chee SP
    Int Ophthalmol Clin; 2012; 52(4):163-72. PubMed ID: 22954938
    [No Abstract]   [Full Text] [Related]  

  • 62. Cluster-like headache as presenting feature of Vogt-Koyanagi-Harada disease.
    Kanaujia V; Paliwal VK; Aneez A; Agarwal R
    Neurol India; 2014; 62(6):681-3. PubMed ID: 25591688
    [No Abstract]   [Full Text] [Related]  

  • 63. [The Vogt-Koyanagi-Harada uveomeningoencephalitic syndrome].
    Menger H; Neukäter W; Kroll S; Jörg J
    Nervenarzt; 1994 Aug; 65(8):553-6. PubMed ID: 7969653
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vogt-Koyanagi-Harada disease in the developing world.
    Concha del Río LE; Arellanes-García L
    Int Ophthalmol Clin; 2010; 50(2):189-99. PubMed ID: 20375871
    [No Abstract]   [Full Text] [Related]  

  • 65. Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.
    Errera MH; Fardeau C; Cohen D; Navarro A; Gaudric A; Bodaghi B; Westcott M; LeHoang P
    Acta Ophthalmol; 2011 Jun; 89(4):e357-66. PubMed ID: 21251241
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vogt-koyanagi-harada syndrome manifestations and diagnosis.
    Katsimpris JM; Theoulakis PE; Lepidas J; Livieratou A; Petropoulos IK
    Klin Monbl Augenheilkd; 2011 Apr; 228(4):368-71. PubMed ID: 21484655
    [No Abstract]   [Full Text] [Related]  

  • 67. Vogt-Koyanagi-Harada syndrome--a case report.
    Yusof Z; Pratap RC; Nor M; Reddy TN
    Med J Malaysia; 1990 Mar; 45(1):70-3. PubMed ID: 2152072
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Each one case of Vogt-Koyanagi-Harada disease with vestibular and cerebellar ataxia, and multiple cranial nerve palsies].
    Hiraki Y; Kuwasaki N; Shoji H; Kaji M; Kuboshiro T
    Rinsho Shinkeigaku; 1989 Jan; 29(1):54-8. PubMed ID: 2663296
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A case of scleroderma with sclerodermic renal crisis and association with the Vogt-Koyanagi-Harada syndrome].
    Cavalli C; Gobbi PG; Colombo R; Riccardi A; Gorini M; Ascari E
    Presse Med; 1985 May; 14(20):1131-4. PubMed ID: 3158979
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vogt-Koyanagi-Harada disease: a disorder unfamiliar to dermatologists.
    Hernández-Bel P; Montero J; Hernández-Bel L; Torrijos-Aguilar A
    Actas Dermosifiliogr; 2013; 104(6):529-31. PubMed ID: 23098571
    [No Abstract]   [Full Text] [Related]  

  • 71. Bilateral vestibular impairment in Vogt Koyanagi Harada syndrome: a case report.
    Colnaghi S; Colagiorgio P; Ramat S; Versino M
    Neurol Sci; 2018 Sep; 39(9):1609-1611. PubMed ID: 29654419
    [No Abstract]   [Full Text] [Related]  

  • 72. [Management of uveomeningitis in internal medicine: Proposal for a diagnostic work-up].
    Abad S; Terrada C; Trad S; Sène D; Bielefeld P; Saadoun D; Sève P
    Rev Med Interne; 2016 Jan; 37(1):25-34. PubMed ID: 26541836
    [TBL] [Abstract][Full Text] [Related]  

  • 73. UVEOMENINGOENCEPHALITIC SYNDROME (VOGT-KOYANAGI-HARADA).
    PATTISON EM
    Arch Neurol; 1965 Feb; 12():197-205. PubMed ID: 14237777
    [No Abstract]   [Full Text] [Related]  

  • 74. Tuberculous Posterior Sclero-Uveitis with Features of Vogt-Koyanagi-Harada Uveitis: An Unusual Case.
    Kalogeropoulos D; Kitsos G; Konstantinidis A; Gartzonika C; Svarna E; Malamos K; Katsanevakis E; Kalogeropoulos C
    Am J Case Rep; 2017 Apr; 18():367-374. PubMed ID: 28389634
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical course and poor prognostic factors of Vogt-Koyanagi-Harada disease in a tertiary uveitis clinic.
    Maleki A; Anesi SD; Look-Why S; Asgari S; Manhapra A; Foster CS
    Can J Ophthalmol; 2022 Apr; 57(2):142-144. PubMed ID: 33984288
    [No Abstract]   [Full Text] [Related]  

  • 76. Development of Vogt-Koyanagi-Harada disease-like uveitis during treatment by anti-programmed death-1 antibody: a case report.
    Wang JN; Zhang Y; Huang CY; Li K; Yu XB
    BMC Ophthalmol; 2024 Jun; 24(1):240. PubMed ID: 38849786
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vogt-Koyanagi-Harada disease masquerading anterior ischaemic optic neuropathy.
    Yokoyama A; Ohta K; Kojima H; Yoshimura N
    Br J Ophthalmol; 1999 Jan; 83(1):123. PubMed ID: 10209450
    [No Abstract]   [Full Text] [Related]  

  • 78. Vogt-Koyanagi-Harada syndrome.
    Seals RL; Rise EN
    Arch Otolaryngol; 1967 Oct; 86(4):419-23. PubMed ID: 6041115
    [No Abstract]   [Full Text] [Related]  

  • 79. [One case report of Vogt-Koyanagi-Halada syndrome misdiagnosed of sudden hearing loss].
    Huang W; Yue H; Hu H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 28(13):1000. PubMed ID: 25248274
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bilateral Iris depigmentation, transillumination defects and hypotony in Vogt-Koyanagi-Harada disease.
    Garg M; Das D; Bhattacharjee H; Godani K; Mahapatra M; Raichura R
    Indian J Ophthalmol; 2022 Jul; 70(7):2682-2684. PubMed ID: 35791204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.